Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wŏnju
Clinical trial register · South Korea

Clinical Trials in Wŏnju, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 2821 Daegu 554 Seongnam-si 493 Busan 468 Goyang-si 396
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Wonju Severance Christian Hospital8 Novartis Pharmaceuticals7 AstraZeneca6 Merck Sharp & Dohme LLC6 Eli Lilly and Company5
Site location
Seoul2821 Daegu554 Seongnam-si493 Busan468 Goyang-si396
All 252 locations
Target enrolment
to

Trials with a site in Wŏnju

90 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
By invitation
Wonju Severance Christian Hospital
Not applicable
350
Wŏnju
2026-09-28
Recruiting
BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
NCT07570394Chronic Obstructive Pulmonary Disease (COPD), Asthma
AstraZeneca
Observational
600
Chuncheon, Daegu, Goyang-si, Gwangmyeong, Jinju, Seongnam-si, Seoul, Wŏnju
2026-09-17
Recruiting
AstraZeneca
Phase 3
2,800
Anyang, Cheonan-si, Seoul, Wŏnju, Yangsan
2026-09-01
Recruiting
Eli Lilly and Company
Phase 2
606
Bupyeong-gu, Dongjak-gu, Gyeongsan-si, Seoul, Ulsan, Wŏnju
2026-08-07
Not yet open
Wonju Severance Christian Hospital
Observational
220
Wŏnju
2026-07-01
By invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
NCT07652294Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Wŏnju, Busan, Daegu, Daejeon, Seoul
2026-06-08
Recruiting
Dompé Farmaceutici S.p.A
Phase 3
150
Wŏnju, Gwangju, Bucheon-si, Seoul
2026-06-02
Recruiting
Novartis Pharmaceuticals
Phase 3
5,700
Daegu, Wŏnju, Bundang Gu, Suwon, Incheon, Seoul, Busan, Gwangju
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Wŏnju, Anyang-si, Seongnam-si, Suwon, Uijeongbu-si, Yangsan, Daegu, Daejeon
2026-05-11
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Busan, Daegu, Daejeon, Gwangju, Gyeongsan-si, Pusan, Seoul, Wŏnju
2026-03-26
Recruiting
Merck Sharp & Dohme LLC
Phase 2
100
Wŏnju, Ansan-si, Seoul
2026-03-24
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
NCT07288398Pulmonary Hypertension Associated With HFpEF
DrugTNX-103
Tenax Therapeutics, Inc.
Phase 3
540
Cheongju-si, Gwangju, Incheon, Seoul, Wŏnju
2026-03-03
Recruiting
Insmed Incorporated
Phase 3
344
Incheon, Seoul, Wŏnju
2026-01-07
Active, closed
Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation
NCT07446088Improving Blood Circulation, Blood Circulation
Ceragem Clinical Inc.
Not applicable
40
Wŏnju
2025-12-01
By invitation
QOL and Mental Health Using APD With Remote Monitoring System
NCT07012499Quality of Life, Mental Health Wellness 1
Wonju Severance Christian Hospital
Not applicable
50
Wŏnju
2025-12-01
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
75
Daegu, Daejeon, Seoul, Wŏnju
2025-11-26
Recruiting
Gachon University Gil Medical Center
Phase 4
64
Busan, Chungju, Daegu, Daejeon, Gwangju, Incheon, Seoul, Wŏnju
2025-11-24
Recruiting
Genentech, Inc.
Phase 2
224
Wŏnju, Busan, Daejeon, Gwangju, Seoul
2025-09-29
Recruiting
Traws Pharma, Inc.
Phase 2
90
Gwangju, Seoul, Wŏnju, Incheon
2025-09-16
Not yet open
Wonju Severance Christian Hospital
Not applicable
200
Wŏnju
2025-09-01
Recruiting
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
NCT06989359IgAN, C3G, Complement-mediated Kidney Disease, IgA Nephropathy (IgAN)
ADARx Pharmaceuticals, Inc.
Phase 2
45
Wŏnju, Gyeonggi-do, Seoul, Cheonan, Daegu
2025-08-28
By invitation
Effect of Daily Chlorhexidine Bathing and Antibiotic/PPI Stewardship on Prevention of CPE Transmission and Infection
NCT07039955Carbapenemase-Producing Enterobacteriaceae (CPE), Healthcare-Associated Infections (HAIs)
Chuncheon Sacred Heart Hospital
Not applicable
5,760
Chuncheon, Gangneung, Wŏnju
2025-07-14
Active, closed
Upstream Bio Inc.
Phase 2
666
Wŏnju, Seongnam-si, Incheon, Seoul
2025-07-02
Recruiting
AstraZeneca
Phase 2
987
Anyang-si, Cheongju-si, Chuncheon, Daegu, Jeonju, Seongnam-si, Seoul, Wŏnju
2025-06-27
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Anyang, Chungju, Daegu, Dong-gu Ulsan, Incheon, Seoul, Wŏnju
2025-06-09
Recruiting
Takeda
Phase 2
192
Haeundae, Wŏnju
2025-05-28
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Busan, Daegu, Daejeon, Seoul, Suwon, Wŏnju
2025-05-27
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Busan, Gwangju, Incheon, Seongnam, Seoul, Wŏnju
2025-05-20
Recruiting
AstraZeneca
Phase 3
990
Anyang-si, Daegu, Iksan-si, Jeonju, Seoul, Uijeongbu-si, Wŏnju
2025-03-18
Recruiting
AstraZeneca
Phase 3
11,300
Bucheon-si, Cheongju-si, Daegu, Seongnam-si, Seoul, Suwon, Wŏnju, Yangsan
2025-03-14
Active, closed
Sanofi
Phase 2
260
Haeundae-Gu, Daegu, Daejeon, Wŏnju
2024-12-10
Recruiting
Pfizer
Phase 3
2,330
Namdong-gu, Tonggu, Wŏnju, Gwangju, Ansan-si, Suwon, Dongjak-gu, Gangnam-gu
2024-12-08
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Wŏnju, Gwangju, Ansan-si, Jinju, Pusan, Deagu, Seoul
2024-12-02
Active, closed
BRPharm Co., Ltd.
Not applicable
128
Wŏnju
2024-11-14
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Bucheon-si, Busan, Incheon, Seoul, Wŏnju
2024-11-12
Recruiting
Chong Kun Dang Pharmaceutical
Phase 3
324
Wŏnju
2024-10-14
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Bucheon-si, Busan, Deagu, Incheon, Seoul, Wŏnju
2024-10-14
Active, closed
Takeda
Phase 3
2,099
Wŏnju, Gwangju, Beon-gil Bundang-gu, Bucheon-si, Gwangjin-Gu, Seocho-Gu, Seoul
2024-09-04
Recruiting
CHA University
Phase 4
490
Seongnam-si, Daegu, Iksan, Ilsan, Seongnam, Seoul, Wŏnju
2024-08-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Wŏnju, Gwangju, Seongnam, Suwon, Cheongju-si, Busan, Haeundae-gu, Daegu
2024-08-05
Recruiting
Real-World Treatment Study of Koselugo (Selumetinib)
NCT06360406Neurofibromatosis 1, Neurofibroma, Plexiform
AstraZeneca
Observational
200
Busan, Chungcheongbuk-do, Daejeon, Gyeonggi-do, Incheon, Jeonnam, Seoul, Wŏnju
2024-06-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Wŏnju, Ansan-si, Suwon, Busan, Haeundae-gu, Dongjak-gu, Daegu, Daejeon
2024-06-05
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Wŏnju, Seoul
2024-05-20
Active, closed
Left Bundle Branch Area Pacing Versus Right Ventricular Pacing in Atrioventricular Block With Preserved Ejection Fraction
NCT07464041Atrioventricular Block, Left Bunde Branch Area Pacing, Conduction System Pacing
Samsung Medical Center
Not applicable
200
Wŏnju, Seoul, Changwon
2024-04-29
Active, closed
Takeda
Phase 2
213
Wŏnju, Busan, Seoul
2024-03-29
Recruiting
Takeda
Phase 2
268
Wŏnju, Busan, Daegu, Seoul
2024-03-05
Recruiting
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
NCT06246123Arthritis, Rheumatoid, Colitis, Ulcerative
Eisai Korea Inc.
Observational
2,040
Cheonan, Chuncheon, Wŏnju, Ansan, Bucheon-si, Goyang-si, Gwangmyeong, Seongnam-si
2024-02-27
Recruiting
Wonju Severance Christian Hospital
Not applicable
588
Gwangju, Wŏnju, Gyeonggi-do, Seoul
2024-02-22
Active, closed
DualityBio Inc.
Phase 3
541
Busan, Wŏnju, Seongnam-si, Seoul, Suwon, Incheon, Cheonan, Ulsan
2024-01-18
Recruiting
Colorado Prevention Center
Phase 3
5,200
Gwangju, Wŏnju, Seoul, Bucheon-si, Incheon, Daejeon, Cheongju-si, Busan
2024-01-17
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugCliramitug
Alexion Pharmaceuticals, Inc.
Phase 3
1,181
Busan, Seoul, Wŏnju
2024-01-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Wŏnju, Goyang-si, Suwon, Cheongju-si, Daegu, Seoul
2023-12-15
Recruiting
Wonju Severance Christian Hospital
Not applicable
100
Wŏnju
2023-12-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Wŏnju, Suwon, Busan, Haeundae-gu, Dongjak-gu, Daegu, Daejeon, Seoul
2023-10-25
Active, closed
Yuhan Corporation
Phase 4
198
Wŏnju, Seoul, Busan, Daejeon, Gwangju, Gyeonggi-do, Incheon
2023-10-18
Recruiting
Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients
NCT06202027FGF23-related Hypophosphataemic Rickets and Osteomalacia
Kyowa Kirin Korea Co., Ltd.
Observational
100
Wŏnju, Suwon, Yangsan, Gwangju, Sejong, Busan, Seoul
2023-08-11
Recruiting
Asciminib RMP Study
NCT05943522Chronic Myeloid Leukemia
Novartis Pharmaceuticals
Observational
600
Wŏnju, Anyang-si, Bucheon-si, Uijeongbu-si, Gyeonggi-do, Incheon, Seoul, Suwon
2023-07-19
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Bucheon-si, Daegu, Gyeonggi-do, Incheon, Jeollabuk-do, Seoul, Wŏnju
2023-06-28
Active, closed
ModernaTX, Inc.
Observational
4,207
Wŏnju, Bucheon-si, Gimpo-si, Goyang-si, Gwangmyeong, Namyangju, Siheung, Yangju
2023-03-10
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Wŏnju, Seongnam-si, Suwon, Daegu, Ansan-si, Busan, Daejeon, Incheon
2023-01-16
Active, closed
Sanofi
Phase 2
68
Haeundae-gu, Daegu, Daejeon, Wŏnju
2023-01-12
Active, closed
Hoffmann-La Roche
Phase 3
1,290
Bucheon-si, Daegu, Gyeonggi-do, Seoul, Wŏnju
2022-12-29
Active, closed
Bellus Health Inc. - a GSK company
Phase 3
997
Busan, Incheon, Jeonju, Seongnam, Seoul, Wŏnju
2022-12-05
Active, closed
Eli Lilly and Company
Phase 3
15,374
Ansan-si, Busan, Seongnam, Seoul, Wŏnju
2022-10-11
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Busan, Daegu, Gwangju, Gyeonggi-do, Hwaseong-si, Seoul, Suwon, Wŏnju
2022-09-19
Active, closed
Yuhan Corporation
Observational
2,001
Chilgok, Chuncheon, Wŏnju, Bucheon-si, Uijeongbu-si, Iksan, Seoul, Busan
2022-06-24
Recruiting
Genoss Co., Ltd.
Observational
1,000
Wŏnju
2022-05-13
Active, closed
Novartis Pharmaceuticals
Observational
670
Daegu, Kangwon Do, Wŏnju, Goyang-si, Guri-si, Jinju, Jeonju, Iksan Si
2022-05-09
Active, closed
Novartis Pharmaceuticals
Observational
683
Daegu, Wŏnju, Bucheon-si, Bundang Gu, Goyang-si, Yangsan, Jeonju, Suncheon
2022-05-09
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Wŏnju, Goyang-si, Seongnam-si, Suwon, Cheongju-si, Seoul, Busan, Incheon
2022-03-07
Recruiting
Zimmer Biomet
Observational
167
Wŏnju, Suwon
2022-01-02
Active, closed
Sanofi
Phase 4
1,339
Busan, Wŏnju, Daegu, Bupyeong-Gu, Seoul
2021-12-16
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Daegu, Wŏnju, Bundang Gu, Jinju, Yangsan, Incheon, Seoul, Cheongju-si
2021-11-23
Recruiting
Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients
NCT06141798Age Problem, Dialysis; Complications, Frailty, Quality of Life
Soonchunhyang University Hospital
Not applicable
428
Bucheon-si, Chuncheon, Seoul, Wŏnju
2021-11-23
Recruiting
Pharmicell Co., Ltd.
Observational
100
Ansan, Bucheon-si, Cheonan, Chuncheon, Gangneung-si, Seoul, Wŏnju, Yongin
2021-09-09
Recruiting
Genoss Co., Ltd.
Observational
1,000
Wŏnju
2021-08-18
Recruiting
Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital
NCT05474963SSNHL(Sudden Sensory Neural Hearing Loss), Sudden Hearing Loss, Hearing Loss, Idiopathic Sudden Sensorineural, Hearing Loss, Sudden
Wonju Severance Christian Hospital
Observational
1,000
Wŏnju
2021-07-14
Recruiting
Pharmicell Co., Ltd.
Phase 3
200
Ansan, Bucheon-si, Cheonan, Chuncheon, Gangneung-si, Seoul, Wŏnju, Yongin
2021-04-19
Active, closed
Novartis Pharmaceuticals
Phase 3
345
Wŏnju, Incheon, Seoul, Gwangju
2021-03-01
Recruiting
CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
NCT04490317Carbon Monoxide Poisoning, Myocardial Injury, Neurologic Deficits, Image, Body
Wonju Severance Christian Hospital
Observational
1,500
Wŏnju
2020-07-29
Active, closed
Eli Lilly and Company
Phase 3
996
Wŏnju, Ansan-si, Guri-si, Suwon, Gyeongsan-si, Busan, Haeundae-gu, Dongjak-gu
2020-06-22
Active, closed
Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery
NCT04585074Breast Neoplasms, Germline BRCA1 Gene Mutation, Germline BRCA2 Gene Mutation, Benign Breast Disease
Severance Hospital
Observational
2,000
Busan, Sejong, Daegu, Wŏnju, Ansan, Goyang-si, Yongin-si, Changwon
2020-04-08
Active, closed
Seung-Jung Park
Observational
2,000
Busan, Chuncheon, Daegu, Gangneung, Seoul, Suncheon, Wŏnju
2019-12-23
Active, closed
Pfizer
Phase 3
896
Wŏnju, Suwon, Busan, Daegu
2019-09-05
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Seoul, Wŏnju, Bundang Gu, Suwon, Gyeonggi-do, Cheongju-si, Incheon, Seongnam Gyeonggi
2018-12-07
Active, closed
Gilead Sciences
Phase 2
502
Daegu, Goyang-si, Gwangju, Hwasun, Seongbuk-Gu, Seoul, Suwon, Wŏnju
2018-08-13
Active, closed
Eli Lilly and Company
Phase 3
1,058
Busan, Daejeon, Gyeongsan-si, Haeundae-gu, Seoul, Wŏnju
2018-07-18
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Busan, Daejeon, Goyang-si, Gwangju, Gyeonggi-do, Incheon, Seoul, Wŏnju
2018-03-23
Active, closed
Daehwa Pharmaceutical Co., Ltd.
Phase 2/3
549
Wŏnju, Goyang-si, Seongnam-si, Suwon, Cheongju-si, Busan, Daegu, Daejeon
2017-12-18
Recruiting
Gangwon PCI Prospective Registry
NCT02038127Coronary Artery Disease, Ischemic Heart Disease (IHD), Unstable Angina (UA), Non-ST Elevated Myocardial Infarction
Yonsei University
Observational
10,000
Chuncheon, Gangneung, Wŏnju
2013-01-01
Rows per page Showing 1–90 of 90
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/w-nju

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 90 of those studies with a site in Wŏnju.

How many clinical trials are recruiting in Wŏnju?

48 of the 90 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 36 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wŏnju), 90 studies
PhaseStudiesRecruitingShare
Phase 3382042.2%
Observational191221.1%
Phase 2181120%
Not applicable10311.1%
Phase 4424.4%
Phase 2/3101.1%

Most active sponsors

Lead sponsors with the most studies (Wŏnju)
Lead sponsorStudiesRecruiting
Wonju Severance Christian Hospital84
Novartis Pharmaceuticals72
AstraZeneca66
Merck Sharp & Dohme LLC64
Eli Lilly and Company52
Boehringer Ingelheim44
Takeda42
Sanofi30
Alexion Pharmaceuticals, Inc.21
Genoss Co., Ltd.22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.